p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response

Mol Endocrinol. 1998 Oct;12(10):1582-93. doi: 10.1210/mend.12.10.0180.

Abstract

Stat5 was discovered as a PRL-induced member of the Stat (signal transducer and activator of transcription) family. Its induction by many other cytokines and interleukins suggests that Stat5 plays a crucial role not only in mammary epithelial, but also in hematopoietic cells. Cell type- and promoter-specific functions of Stat5 are most likely modulated by the interaction with other transcription factors. We recently showed cross-talk between Stat5 and the glucocorticoid receptor. The activated glucocorticoid receptor forms a complex with Stat5 and enhances Stat5-mediated transcriptional induction. Conversely, Stat5 diminishes the induction of glucocorticoid-responsive genes. Here, we investigated the role of p300/CBP(CREB-binding protein), a transcriptional coactivator of several groups of transcription factors, in Stat5-mediated transactivation and in the cross-talk between Stat5 and the glucocorticoid receptor. p300/ CBP acts as a coactivator of Stat5. Its ectopic expression enhances PRL-induced Stat5-mediated transcriptional activation. Consistent with this observation, we find that the adenovirus E1A protein, which binds to p300/CBP, suppresses Stat5-induced transcriptional activation. This inhibition requires the Stat5 transactivation domain and the p300/CBP binding site of E1A. Coimmunoprecipitation and mammalian two-hybrid assays demonstrate a direct interaction between the carboxyl-terminal transactivation domain of Stat5 and p300/CBP. p300/CBP also positively interacts with the glucocorticoid receptor and enhances glucocorticoid receptor-dependent transcriptional activation of the mouse mammary tumor virus-long terminal repeat promoter. Overexpression of p300/CBP does not counteract the Stat5-mediated inhibition of glucocorticoid receptor-dependent transactivation, i.e. the repression of the glucocorticoid response by Stat5 is not a consequence of competition for limiting amounts of p300/CBP.

MeSH terms

  • Adenovirus E1A Proteins / drug effects
  • Adenovirus E1A Proteins / genetics
  • Adenovirus E1A Proteins / metabolism
  • Animals
  • Binding Sites
  • COS Cells / drug effects
  • Cricetinae
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Dexamethasone / pharmacology
  • Glucocorticoids / metabolism*
  • Glucocorticoids / pharmacology
  • HeLa Cells / drug effects
  • HeLa Cells / metabolism
  • Histone Acetyltransferases
  • Humans
  • Mammary Tumor Virus, Mouse / genetics
  • Mice
  • Milk Proteins*
  • Nuclear Receptor Coactivator 3
  • Phosphorylation
  • Prolactin / metabolism*
  • Prolactin / pharmacology
  • Promoter Regions, Genetic
  • Receptors, Glucocorticoid / genetics
  • Receptors, Glucocorticoid / metabolism
  • STAT5 Transcription Factor
  • Terminal Repeat Sequences
  • Trans-Activators / genetics
  • Trans-Activators / metabolism*
  • Transcriptional Activation*
  • Tyrosine / metabolism

Substances

  • Adenovirus E1A Proteins
  • DNA-Binding Proteins
  • Glucocorticoids
  • Milk Proteins
  • Receptors, Glucocorticoid
  • STAT5 Transcription Factor
  • Trans-Activators
  • Tyrosine
  • Dexamethasone
  • Prolactin
  • Histone Acetyltransferases
  • NCOA3 protein, human
  • Ncoa3 protein, mouse
  • Nuclear Receptor Coactivator 3